Bastiano Sanna - 02 May 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
02 May 2023
Net transactions value
-$1,544,186
Form type
4
Filing time
04 May 2023, 16:51:48 UTC
Previous filing
14 Apr 2023
Next filing
09 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $494,302 -1,411 -3.6% $350.32 38,302 02 May 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale $14,769 -42 -0.11% $351.65 38,260 02 May 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale $59,698 -169 -0.44% $353.24 38,091 02 May 2023 Direct F1, F2, F5
transaction VRTX Common Stock Sale $719,453 -2,053 -5.4% $350.44 36,038 03 May 2023 Direct F1, F2, F6
transaction VRTX Common Stock Sale $255,965 -728 -2% $351.60 35,310 03 May 2023 Direct F1, F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1, which was entered into on 08/10/2022.
F2 Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $350.32 (range $350.00 to $350.92).
F4 Open market sales reported on this line occurred at a weighted average price of $351.65 (range $351.48 to $351.80).
F5 Open market sales reported on this line occurred at a weighted average price of $353.24 (range $353.21 to $353.49).
F6 Open market sales reported on this line occurred at a weighted average price of $350.44 (range $350.00 to $350.94).
F7 Open market sales reported on this line occurred at a weighted average price of $351.60 (range $351.01 to $352.00).